| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 3 |
| 1 | BLINATUMOMAB | 2 |
| 2 | DEXLANSOPRAZOLE | 2 |
| 3 | FLUDARABINE PHOSPHATE | 2 |
| 4 | INOTUZUMAB OZOGAMICIN | 2 |
| 5 | INSULIN DEGLUDEC | 2 |
| 6 | ITRACONAZOLE | 2 |
| 7 | LINAGLIPTIN | 2 |
| 8 | MELPHALAN | 2 |
| 9 | MELPHALAN HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 1 | PASIREOTIDE | 1 | 0.0004 |
| 2 | ETELCALCETIDE | 1 | 0.0003 |
| 3 | PEGVISOMANT | 1 | 0.0002 |
| 4 | LANTHANUM CARBONATE | 1 | 0.0002 |
| 5 | BLINATUMOMAB | 2 | 0.0002 |
| 6 | ITRACONAZOLE | 2 | 0.0002 |
| 7 | LINAGLIPTIN | 2 | 0.0001 |
| 8 | IRON SUCROSE | 1 | 0.0001 |
| 9 | INSULIN DEGLUDEC | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 5 |
| 1 | Insulin Analog [EPC] | 3 |
| 2 | Azole Antifungal [EPC] | 2 |
| 3 | CD22-directed Immunoconjugate [EPC] | 2 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 6 | Benzodiazepine [EPC] | 1 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 1 |
| 8 | Estrogen [EPC] | 1 |
| 9 | Loop Diuretic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 1 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 5 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 5 | 0.0000 |
| 8 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 3 | 0.0000 |